Enzychem Lifesciencescorp Kosdaq 183490Is A Global Biopharmaceutical Company Headquartered In Seoulkoreawhich Is Dedicated To Developing New Drugs And Apisactive Pharmaceutical Ingredients Since Its Foundation In 1999Enzychem Lifesciences Has Been Striving To Develop New And Innovative Treatments Capable Of Addressing Unmet Medical Needs With R&D Driven Approaches Under Its Grand Mission Ofsaving Human Lives By Overcoming Unmet Medical Needs Ae Ec 18The Lead Compound Of Enzychem Lifesciencesis An Immune Modulator Driven From Deer Antler That Has The Potential To Be Used For A Variety Of Indicationsat Presentthree Clinical Trials For Different Indications Are Being Conductedchemotherapy Induced Neutropeniacin Chemoradiation Induced Oral Mucositiscriom And Acute Radiation Syndromears In Order To Facilitate The Clinical Trial Processenzychem Launched A Us Operation Office In New Jersey On June 282018 Currentlyenzychem Lifesciences Is One Of The Fastest Growing Life Science Companies In Kosdaq Stock Exchange In Terms Of Market Capitalizationthe Company Is Headquartered In Seoulkorea
